MedPath

THIAMINE HYDROCHLORIDE

Thiamine Hydrochloride Injection, USPRx only

Approved
Approval ID

e2b6bd0c-6e45-4edb-8c2a-df1564e6d367

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 14, 2023

Manufacturers
FDA

Lupin Pharmaceuticals, Inc.

DUNS: 089153071

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

THIAMINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70748-347
Application NumberANDA215692
Product Classification
M
Marketing Category
C73584
G
Generic Name
THIAMINE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 14, 2023
FDA Product Classification

INGREDIENTS (4)

THIAMINE HYDROCHLORIDEActive
Quantity: 100 mg in 1 mL
Code: M572600E5P
Classification: ACTIR
MONOTHIOGLYCEROLInactive
Code: AAO1P0WSXJ
Classification: IACT
CHLOROBUTANOL HEMIHYDRATEInactive
Code: 3X4P6271OX
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.